PTHS
Pelthos Therapeutics Inc.
20.50$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 38.8% | 40.4% | 47.5% | 46.1% | |
| 100.0% | 93.5% | 92.4% | 58.6% | 37.5% | 14.4% | 7.2% | 11.3% | 13.8% | 22.2% | 17.9% | |
| 100.0% | 93.5% | 92.4% | 58.6% | 37.5% | 14.4% | 7.2% | 11.3% | 13.8% | 22.2% | 17.9% | |
| – | 1.0% | 1.6% | 1.9% | 3.0% | 4.4% | 4.9% | 6.3% | 6.8% | 8.0% | 10.5% | |
| – | – | – | – | 0.0% | – | – | 19.1% | 18.1% | 16.1% | 15.6% | |
| – | – | – | – | 0.0% | – | – | 24.2% | 18.9% | 17.0% | 18.0% | |
| – | – | – | – | – | – | – | 25.7% | 30.3% | 26.4% | 27.2% | |
| 6,785.8% | 72.0% | 107.0% | 166.7% | 298.2% | 560.5% | 889.2% | 53.9% | 70.2% | 75.9% | 101.1% | |
| 6,785.8% | 72.0% | 107.0% | 166.7% | 298.2% | 560.5% | 889.2% | 19.6% | 19.9% | 17.2% | 23.3% | |
| 1,316.2% | – | 61.0% | 106.9% | 159.7% | 274.7% | 280.1% | 0.5% | 0.5% | 0.4% | 0.5% | |
| 4,793.9% | 59.7% | 32.1% | 59.8% | 138.6% | 285.7% | 606.3% | 4.5% | 2.3% | 4.2% | 4.3% | |
| – | – | – | – | – | – | – | – | 24.1% | 16.0% | 50.9% | |
| -6,685.8% | 28.0% | -7.0% | -66.7% | -198.2% | -460.5% | -789.2% | 46.1% | 29.8% | 24.1% | -1.1% | |
| -14,025.8% | -398.9% | -685.7% | -913.5% | -1,568.5% | -2,572.8% | -3,268.1% | -34.1% | -49.7% | -51.6% | -82.5% | |
| 609.8% | 11.6% | 22.2% | 27.1% | 43.5% | 67.3% | 77.8% | 0.5% | 2.4% | 2.3% | 2.6% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.